The PE Ratio as of November 2024 (TTM) for ReShape Lifesciences Inc. (RSLS) is 0.07

According to ReShape Lifesciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.07. This represents a change of -111.03% compared to the average of -0.63 of the last 4 quarters.

ReShape Lifesciences Inc. (RSLS) Historical PE Ratio (quarterly & annually)

How has RSLS PE Ratio performed in the past?

The mean historical PE Ratio of ReShape Lifesciences Inc. over the last ten years is -1.68. The current 0.07 PE Ratio has changed -515.84% with respect to the historical average. Over the past ten years (40 quarters), RSLS's PE Ratio was at its highest in in the June 2018 quarter at -0.00. The PE Ratio was at its lowest in in the December 2015 quarter at -1770.73.

ReShape Lifesciences Inc. (RSLS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ReShape Lifesciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ReShape Lifesciences Inc. (RSLS) Average PE Ratio

How has RSLS PE Ratio performed in the past?

The current PE Ratio of ReShape Lifesciences Inc. (RSLS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ReShape Lifesciences Inc. (RSLS) PE Ratio vs. Peers

How is RSLS’s PE Ratio compared to its peers?

ReShape Lifesciences Inc.’s PE Ratio is greater than Sintx Technologies, Inc. (-0.38), greater than Bone Biologics Corporation (-0.30), greater than Ra Medical Systems, Inc. (-1.15), greater than Tivic Health Systems, Inc. (-0.24), greater than Nuwellis, Inc. (-0.11), greater than Talis Biomedical Corporation (-0.06), greater than Tenon Medical, Inc. (-0.16), greater than INVO Bioscience, Inc. (-0.42), greater than Helius Medical Technologies, Inc. (-0.19), greater than Heart Test Laboratories, Inc. (-0.28), greater than NeuroMetrix, Inc. (-1.12), greater than Inspira Technologies Oxy B.H.N. Ltd. (-2.58), greater than OpGen, Inc. (-0.93),

Build a custom stock screener for ReShape Lifesciences Inc. (RSLS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ReShape Lifesciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ReShape Lifesciences Inc. (RSLS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ReShape Lifesciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.